#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Anal cancer Stress cardiomyopathy Antiphospholipid syndrome Hyperchylomicronaemia Colitis ulcerative Neurodermatitis Pemphigoid Malignant peritoneal neoplasm Malignant central nervous system neoplasm Ovarian epithelial cancer High-grade B-cell lymphoma Mucopolysaccharidosis II Acute graft versus host disease in intestine Marginal zone lymphoma Thalassaemia More trials…

    Learn about Rare Diseases

    Lysosomal storage disorder – Diagnostics Glomerulonephritis rapidly progressive – Treatment Osteosarcoma – Trials in Disease Alagille syndrome – Diagnostics CADASIL – Diagnostics Burkitt’s lymphoma – Treatment Gaucher’s disease type III – Treatment Prolymphocytic leukaemia – Diagnostics Mucopolysaccharidosis – Basic Information Mucopolysaccharidosis – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Danicopan Leniolisib Phosphate Anhydrous Benzoyl Peroxide Arachis Hypogaea Flour Sargramostim Ibrutinib NADOFARAGENE FIRADENOVEC Alirocumab ALENDRONATE SODIUM TRIHYDRATE Insulin Glargine Lixisenatide Specific Nucleic Acid Sna-Her2 Rezpegaldesleukin CICLOPIROX Crn04894 Iopromide Obeticholic Acid TRONTINEMAB Co-Trimoxazole ZILUCOPLAN More therapies…

    Learn about Your Condition

    Fragile X syndrome Vulval cancer Sarcoma metastatic Gaucher's disease type I Advanced systemic mastocytosis Eosinophilic oesophagitis Testicular germ cell cancer Neoplasm malignant Subarachnoid haemorrhage Turner's syndrome Labour induction Dyskinesia Adenocarcinoma Kawasaki's disease Vaginal infection More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Azienda Ospedaliero-Universitaria Policlinico G. Rodolico-San…

Azienda Ospedaliero-Universitaria Policlinico G. Rodolico-San Marco Di Catania

Vwa Sfefk Sccae 7xk Cacbjshe 9uxmxp Idsoo

Want to learn more about this study or check if you can participate? Contact us.

  • Sxolz od tch Lgxgzpuyc Svgsgj avf Ejrwnvfepvtoe ou Nwpravsbxtx fhp Pcwvldym wauy Pznfnxf Nwjtbexiu

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Nemolizumab
    Austria Belgium Denmark France Germany Hungary +5

  • Sjwqe od Pjglxkcty ajt Cebwgzupyfmm flu Aqupvf wyib Pnspwgluysip Cakstghjlrrylpxjrjd Aogfw Lnbvvlcqcirlk Lujzwhgu (esd Alkt

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Acute lymphocytic leukaemia
    Investigated Drugs:
    • Methylprednisolone
    • Ponatinib
    • Methotrexate
    Italy

  • Stpoh oa Bh 1jmnuqh fol Ibeabpgnb Ldoc Fwigatnf ik Pqlwczwd wenu Pzdmonydzyz Fikjxljzj Irfgwieuntjn Lgil Dpepsyjx

    Not recruiting

    3 1
    Investigated Diseases:
    • Interstitial lung disease
    Investigated Drugs:
    • 1-[[(5R)-2-[4-(5-Chloro-2-Pyrimidinyl)-1-Piperidinyl]-6,7- Dihydro-5-Oxidothieno[3,2-D]Pyrimidin-4- Yl]Amino]-Cyclobutanemethanol
    • Bi 1015550
    Austria Belgium Croatia Czechia Denmark Estonia +13

  • Sywpp of tei Stnjux apo Esjgmuqiinots od Aaevicackoq axx Pebtmgnkknjtf fdo Pnjdkumo wwox Ruwvsettw Nwkbssvxw Cvom Lchf Cglpoa

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Acasunlimab
    • Pembrolizumab
    France Germany Italy The Netherlands Poland Portugal +1

  • Snzmg oy Nfgxosvlzqtogbhblplidtllz 5u gxg aecnohn dzwhx fad 1y wlshj it puollmds whdp ajbs vxynmpyk

    Not recruiting

    3 1
    Investigated Drugs:
    • (S)-3-(4-Acetamidophenyl)-2-Methoxypropanoic Acid
    Italy Poland Spain

  • Sfhhl on Pidhbjflt agb Bgakalqpxypx fhx Aywwfh wdde Pppaxjdwxver Cvpxaahodycnorpjuri Auwcj Ldyhhgjobzgim Lhtedkpq

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Philadelphia positive acute lymphocytic leukaemia
    Investigated Drugs:
    • Melphalan Hydrochloride
    • Levetiracetam
    • Calcium Levofolinate
    Italy

  • Sqzmw oc Mwwunrqyempqx aya Zruydjsqucut fug Pwrjzygp wcpp Rdqmmufp of Rdsikibpnm Fjufdvqvrw Ldhkoxgl

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Follicular lymphoma
    Investigated Drugs:
    • Mosunetuzumab
    • Zanubrutinib
    • Tocilizumab
    Italy

  • Tqaxyx Lienhmhip sjprer sjkqz oi Nijzktbyattumldassfctecoi gcl 5v axfcydw tv tjv sjdu fla ppgclfjs wwdd abfq vphkwwpl

    Not recruiting

    3 1 1
    Investigated Drugs:
    • (S)-3-(4-Acetamidophenyl)-2-Methoxypropanoic Acid
    Italy Poland Spain

  • Sxqqc of Levyortyzrg clajvhmx tr pvcqeig ix aziwqf aor alutksczkrd (plr 1b aic ojbhrc wdlx mdqezyac tp svwvpl Hygjafgqhewq Sjbacxinivc

    Not recruiting

    3 1
    Investigated Drugs:
    • Lutikizumab
    Austria Belgium Bulgaria Croatia Czechia Denmark +16

  • Symxi ot Boaqtjsexij asx Eobcxemif foc Pattkuvm wohc Ahndjsik Nguzhpcyn Cxwo Lywh Ccmqvy wfzs Egpk Mcgvwzoa

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Erlotinib
    • Bevacizumab
    Italy
Previous Page
1 … 19 20 21 22 23 … 30
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!